Skip to Content
Stock Strategist Industry Reports

Slow Burn Likely Until Coronavirus Vaccines Are Widely Available

Resurgences in outbreaks make it clear that ending the pandemic will require more than diagnostic testing, contact tracing, and social distancing.

Mentioned: , , , , , , , , ,

Since our May update, U.S. coronavirus cases have surged higher than we expected for several reasons.

  • Initial increases in cases have not been consistently met with a pullback in reopening plans or more aggressive individual efforts at good hygiene, masking, and distancing.
  • The supply of diagnostics has increased, but shortages still exist, and long turnaround times can make results irrelevant unless patients opt to self-quarantine while waiting for results.
  • Contact tracing has been hampered by the sheer number of cases to trace with limited staff, long diagnostics wait times, and poor uptake for app-based tracing technologies.

Karen Andersen has a position in the following securities mentioned above: DGX. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.